203
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Ophthalmic Manifestations Among Patients Surviving COVID-19

, , , , , , ORCID Icon, & show all
Pages 1747-1755 | Received 07 Dec 2022, Accepted 20 Mar 2023, Published online: 09 May 2023

References

  • World Health Organization. WHO Coronavirus Disease (COVID-19) dashboard; 2021. Available from: https://covid19.who.int/. Accessed April 13, 2023.
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
  • Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574. doi:10.1016/S0140-6736(20)30251-8
  • Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720. doi:10.1056/NEJMoa2002032
  • Romero-Castro RM, Ruiz-Cruz M, Alvarado-de la Barrera C, et al. Posterior Segment Ocular Findings In Critically Ill Patients with COVID-19. Retina. 2022;42(4):628–633. doi: 10.1097/IAE.0000000000003457
  • Lai CC, Ko WC, Lee PI, Jean SS, Hsueh PR. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents. 2020;56(2):106024. doi:10.1016/j.ijantimicag.2020.106024
  • Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138(5):575–578. doi:10.1001/jamaophthalmol.2020.1291
  • Marinho PM, Marcos AAA, Romano AC, Nascimento H, Belfort R Jr. Retinal findings in patients with COVID-19. Lancet. 2020;395(10237):1610. doi:10.1016/S0140-6736(20)31014-X
  • Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020;92(6):589–594. doi:10.1002/jmv.25725
  • Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1022–1034. doi:10.1016/S0140-6736(20)30628-0
  • Wong TY, Klein R, Sharrett AR, et al. The prevalence and risk factors of retinal microvascular abnormalities in older persons: the cardiovascular health study. Ophthalmology. 2003;110(4):658–666. doi:10.1016/S0161-6420(02)01931-0
  • Pereira LA, Soares LCM, Nascimento PA, et al. Retinal findings in hospitalised patients with severe COVID-19. Br J Ophthalmol. 2020;106:102–105. doi:10.1136/bjophthalmol-2020-317576
  • Casagrande M, Fitzek A, Püschel K, et al. Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocul Immunol Inflamm. 2020;28(5):721–725. doi:10.1080/09273948.2020.1770301
  • Invernizzi A, Torre A, Parrulli S, et al. Retinal findings in patients with COVID-19: results from the SERPICO-19 study. EClinicalMedicine. 2020;27:100550. doi:10.1016/j.eclinm.2020.100550
  • Pirraglia MP, Ceccarelli G, Cerini A, et al. Retinal involvement and ocular findings in COVID-19 pneumonia patients. Sci Rep. 2020;10(1):1–7. doi:10.1038/s41598-020-74446-6
  • Ministério da Saúde. [Brazilian Ministry of Health]. Emergência de Saúde Pública de Importância Nacional pela Doença pelo Coronavírus 2019: vigilância Integrada de Síndromes Respiratórias Agudas Doença pelo Coronavírus 2019, Influenza e outros vírus respiratórios. [Public Health Emergency of National Concern for Coronavirus Disease 2019: Integrated Surveillance of Acute Respiratory Syndromes Coronavirus Disease 2019, Influenza and other respiratory viruses]; 2020. Available from: https://portalarquivos.saude.gov.br/images/pdf/2020/April/07/GuiaDeVigiEpidemC19-v2.pdf. Accessed April 13, 2023. Spanish.
  • Sgorlon G, Queiroz JADS, Roca TP, et al. Clinical and epidemiological aspects of delta and gamma SARS-CoV-2 variant of concern from the western Brazilian Amazon. Mem Inst Oswaldo Cruz. 2022;117:e220155. doi:10.1590/0074-02760220155
  • Landecho MF, Yuste JR, Gándara E, et al. COVID‐19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? J Intern Med. 2020;289(1):116–120. doi:10.1111/joim.13156
  • Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418. doi:10.1016/S0140-6736(20)30937-5
  • Jaworski C. Morphology of the HIV versus the diabetic cottonwool spot. Optom Vis Sci. 2000;77(11):600–604. doi:10.1097/00006324-200011000-00010
  • Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586–590. doi:10.1007/s00134-020-05985-9
  • Raony Í, Figueiredo CS. Retinal outcomes of COVID-19: possible role of CD147 and cytokine storm in infected patients with diabetes mellitus. Diabetes Res Clin Pract. 2020;165:108280. doi:10.1016/j.diabres.2020.108280
  • Guzzi PH, Mercatelli D, Ceraolo C and Giorgi FM. Master Regulator Analysis of the SARS-CoV-2/Human Interactome. J Clin Med. 2020;9(4):982. doi:10.3390/jcm9040982
  • Kochi AN, Tagliari AP, Battista Forleo G, Fassini GM, Tondo C Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020;31(5):1003–1008. doi:10.1111/jce.14479
  • Iba T, Levy JH, Levi M, Connors JM, Thachil J Coagulopathy of Coronavirus Disease 2019. Crit Care Med. 2020;48(9):1358–1364. doi:10.1097/CCM.0000000000004458